Planes with the Corona vaccine took off in preparation for zero hours – Covid-19



After the German company Biontec and the US company Pfizer previously confirmed that the vaccine may be on the market in December, it seems preparations are underway.

Today, Saturday, US media reported that US “United Airlines” planes began to carry thousands of doses of Pfizer’s vaccine against Coronavirus and collect it from specific centers, with the aim of speeding up the distribution process later.

In context, the Wall Street Journal cited informed sources as saying that these first journeys were launched within a broad global supply chain that is being planned to address any difficulties or challenges that could hinder the delivery of the vaccine, requiring specific storage conditions.

According to the paper, the distribution plan has identified refrigerated storage sites in final assembly centers in various regions, such as Michigan in the United States and Borsa, Belgium, in addition to Karlsruhe in Germany, among others.

In addition, the Federal Aviation Administration announced in a statement that it is working with airlines to safely transport vaccines. While the newspaper disclosed that United Company has been allowed to carry larger amounts of dry ice than is normally allowed on flights, in order to maintain the very low temperatures required by the conditions for the storage of the vaccine and its transportation (70 degrees below zero), said Al Arabiya Net.

It is noteworthy that the conditions for storage and transport of the Pfizer vaccine require exceptional temperatures that the vaccines do not usually require. UK Health Secretary Matt Hancock spoke in a TV interview last week about a very significant obstacle to the transportation of the Pfizer / Bionic vaccine from the place of manufacture to those who will receive it, noting that it is preserved. must stay at a temperature of 70 degrees below zero, and it cannot be put it at a higher temperature, more than four times during its transportation journey.

There is no doubt that this necessary condition for the preservation of this vaccine, which has been a door of hope for millions around the world, is an absolutely significant obstacle to the process of moving it from factories to hospitals.

This problem is a major challenge for many countries, as most known vaccines do not require a low temperature, and therefore most hospitals do not have an infrastructure that will allow them to handle this new vaccine.

Print
E-mail





Source link